New, Promising Clinical Trial for Glioblastoma Starting at UNC Health
University of North Carolina Health Care SystemUNC Health is the only academic healthcare system in North Carolina and the South participating in the randomized trial, which aims to assess the safety and efficacy of a combination immunotherapy for newly diagnosed glioblastoma patients.